Forian Inc. to Discuss Third Quarter 2025 Results Following Strategic Expansion

Forian Inc. (Nasdaq: FORA) will host a conference call and webcast at 4:30 p.m. ET on November 14, 2025, to discuss its third quarter 2025 financial results. The company, which provides data science driven information and analytics solutions to life science, healthcare and financial services industries, will report its results in a press release prior to the call. This quarterly earnings announcement provides critical insights into the company's performance following its expansion into financial services through the acquisition of Kyber Data Science.

The webcast will be available live at https://edge.media-server.com/mmc/p/dyiaxrbd. This information is also accessible through the company's investor relations website at https://www.forian.com/investors. Following the call's conclusion, both the earnings release and a replay of the conference call will be promptly available at the same investor relations site.

Forian's quarterly results are closely monitored by investors and industry analysts as the company operates at the intersection of healthcare data analytics and financial services. The company specializes in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its information products utilize sophisticated data management and data science capabilities layered over a comprehensive clinical data lake to identify unique relationships and generate proprietary insights.

The third quarter results will be particularly significant as they may reflect the early impact of Forian's expanded capabilities following the Kyber Data Science acquisition. This strategic move extended the company's reach beyond traditional healthcare and life sciences sectors into financial services, potentially creating new revenue streams and market opportunities. The company's performance indicators typically include measures of operational, clinical and financial performance optimization for customers across multiple industry segments.

Investors will be watching for signals about how effectively Forian is leveraging its data science expertise across both established and new market segments. The company's ability to translate complex healthcare data into actionable insights has positioned it as a key player in the growing health data analytics market. The quarterly results will provide valuable information about market adoption of Forian's expanded service offerings and the company's progress in integrating its recent acquisition.